ETENDERS

Contract notice

Information

Published

Date of dispatch of this notice: 29/03/2021

Expire date: 28/04/2021

External Reference: 2021-224395

TED Reference: 2021/S 065-163340

Contract notice

Contract notice

Directive 2014/24/EU

Section I: Contracting authority

I.1)

Name and addresses

Royal College of Surgeons in Ireland
N/A
123 St Stephens Green
Dublin
Dublin 2
IE
Contact person: Brian Kirby
Telephone: +353 14025121
E-mail: bkirby@rcsi.ie
NUTS code:  IE061 -  Dublin
Internet address(es):
Main address: www.rcsi.com
Address of the buyer profile: https://irl.eu-supply.com/ctm/Company/CompanyInformation/Index/362

I.3)

Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at:  
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=185677&B=ETENDERS_SIMPLE
Additional information can be obtained from
the abovementioned address:  
Tenders or requests to participate must be submitted
electronically via:  http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=185677&B=ETENDERS_SIMPLE
Tenders or requests to participate must be submitted
to the abovementioned address
I.4)

Type of the contracting authority

Other type:  Educational facility
I.5)

Main activity

Education

Section II: Object

II.1)

Scope of the procurement

II.1.1)

Title

Provision of genomic medicine software and teaching for the RCSI “enabling future pharma, beyond the pill’ project in accordance with programme requirements.
Reference number:  RCSI_GenomicMedicine
II.1.2)

Main CPV code

48000000  -  Software package and information systems
II.1.3)

Type of contract

Supplies
II.1.4)

Short description

‘Enabling Future Pharma – Beyond the Pill’, is developing a suite of innovative and agile programmes aimed to create a skilled talent pool focused on emerging and future pharma technologies, addressing skills gaps in industry and enabling future growth. Specifically, RCSI and its partners are developing a MSc in Precision Medicine and Innovation and a BSc in Advanced Therapeutic Technologies. These two programmes will be delivered using cutting edge educational technology to maximise flexible delivery. Learning outcomes will focus on technological knowledge and skills, in combination with transversal skills.
In order to develop and implement these programmes, RCSI requires access to software that enables students in the diagnostic interpretation of whole genome and exome next-generation sequence data. In addition, we require industry-informed teaching in specific areas related to the clinical application of genomics.
II.1.5)

Estimated total value

Value excluding VAT: 500000.00  EUR
II.1.6)

Information about lots

This contract is divided into lots: no
II.2)

Description

II.2.2)

Additional CPV code(s)

48100000  -  Industry specific software package
48180000  -  Medical software package
48190000  -  Educational software package
48461000  -  Analytical or scientific software package
II.2.3)

Place of performance

NUTS code:  IE061 -  Dublin
Main site or place of performance:  
Dublin
II.2.4)

Description of the procurement

‘Enabling Future Pharma – Beyond the Pill’, is developing a suite of innovative and agile programmes aimed to create a skilled talent pool focused on emerging and future pharma technologies, addressing skills gaps in industry and enabling future growth. Specifically, RCSI and its partners are developing a MSc in Precision Medicine and Innovation and a BSc in Advanced Therapeutic Technologies. These two programmes will be delivered using cutting edge educational technology to maximise flexible delivery. Learning outcomes will focus on technological knowledge and skills, in combination with transversal skills.
In order to develop and implement these programmes, RCSI requires access to software that enables students in the diagnostic interpretation of whole genome and exome next-generation sequence data. In addition, we require industry-informed teaching in specific areas related to the clinical application of genomics.
II.2.5)

Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)

Estimated value

Value excluding VAT: 500000.00  EUR
II.2.7)

Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 48
This contract is subject to renewal: no
II.2.10)

Information about variants

Variants will be accepted: no
II.2.11)

Information about options

Options: no
II.2.13)

Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no

Section III: Legal, economic, financial and technical information

III.1)

Conditions for participation

III.1.2)

Economic and financial standing

Selection criteria as stated in the procurement documents
III.1.3)

Technical and professional ability

Selection criteria as stated in the procurement documents
III.2)

Conditions related to the contract

Section IV: Procedure

IV.1)

Description

IV.1.1)

Type of procedure

Open procedure
IV.1.8)

Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement : yes
IV.2)

Administrative information

IV.2.2)

Time limit for receipt of tenders or requests to participate

Date:  28/04/2021
Local time:  12:00
IV.2.4)

Languages in which tenders or requests to participate may be submitted

English
IV.2.6)

Minimum time frame during which the tenderer must maintain the tender

Tender must be valid until:  28/07/2021
IV.2.7)

Conditions for opening of tenders

Date:  28/04/2021
Local time:  12:00

Section VI: Complementary information

VI.1)

Information about recurrence

This is a recurrent procurement:  no
VI.4)

Procedures for review

VI.4.1)

Review body

RCSI
Dublin
IE